Generoso Ianniciello M.Sc., Chief Business Officer

Generoso Ianniciello is a strategic leader in life sciences with expertise in multi-omics, diagnostics, biopharma, and platform services. As Chief Business Officer at Anima Biotech, he leads the global strategy for the Biology GPU - a new category in drug discovery infrastructure that connects how AI thinks with how biology works, tackling one of the biggest challenges in the field.

Previously, as CBO at Dante Genomics, he scaled the start-up into a global enterprise with over 200 employees and $100 million in annual revenue. He launched the Dante MyGenome Platform for longevity, personalized medicine, and rare disease diagnostics, and built key partnerships with hospitals, biopharma, and research institutions worldwide.

During the COVID-19 pandemic, as Senior Director of Innovation, Generoso managed the setup of large-scale labs in Italy, the UK, and Dubai, and established molecular biology labs on 90 cruise ships, conducting over 3 million RT-PCR tests.

Generoso holds an MSc in Health Biology and a BSc in Biology from the University of L’Aquila, with research experience in Molecular Biology from the University of Aberdeen in Scotland.